Reading List
The most recent articles from a list of feeds I subscribe to.
Deep dive on the evolution of Microsoft's relationship with OpenAI, from its $1B investment in 2019 through Copilot rollouts and ChatGPT's launch to present day (Bloomberg)
Bloomberg:
Deep dive on the evolution of Microsoft's relationship with OpenAI, from its $1B investment in 2019 through Copilot rollouts and ChatGPT's launch to present day — Nervous customers and a volatile partnership with OpenAI are complicating things for Satya Nadella and the world's most valuable company.
Carta: VC deals are stalling at seed, with the Series A deal count falling by 79% between Q1 2022 and Q1 2025; 46% of seed deals were bridge rounds in Q1 2025 (Dan Primack/Axios)
Dan Primack / Axios:
Carta: VC deals are stalling at seed, with the Series A deal count falling by 79% between Q1 2022 and Q1 2025; 46% of seed deals were bridge rounds in Q1 2025 — Top of the Morning — Venture capital's series progression is stalling at seed, according to new data released this morning by Carta.
London-based Granola, which provides an AI-based notetaking app, raised a $43M Series B led by NFDG at a $250M valuation, taking its total funding to $67M (Ivan Mehta/TechCrunch)
Ivan Mehta / TechCrunch:
London-based Granola, which provides an AI-based notetaking app, raised a $43M Series B led by NFDG at a $250M valuation, taking its total funding to $67M — AI-powered notetaking tool Granola has been on a roll. The startup's seen a steep uptick in usage since it launched a year ago …
Utah-based property management software firm Entrata raised $200M from Blackstone at a $4.3B valuation; Entrata raised $507M from Silver Lake and others in 2021 (Reuters)
Reuters:
Utah-based property management software firm Entrata raised $200M from Blackstone at a $4.3B valuation; Entrata raised $507M from Silver Lake and others in 2021 — Entrata on Thursday announced a $200 million minority investment from alternative asset manager Blackstone (BX.N) …
Boston-based PhaseV, which is developing AI software to accelerate clinical trials and drug development, raised a $50M Series A co-led by Accel and Insight (Aaron Weitzman/Axios)
Aaron Weitzman / Axios:
Boston-based PhaseV, which is developing AI software to accelerate clinical trials and drug development, raised a $50M Series A co-led by Accel and Insight — PhaseV, a clinical trial and development software startup, raised a $50 million Series A, CEO Raviv Pryluk tells Axios exclusively.